HK1210967A1 - 用於行為、精神和認知障礙的預防和治療的組合物 - Google Patents

用於行為、精神和認知障礙的預防和治療的組合物

Info

Publication number
HK1210967A1
HK1210967A1 HK15111940.1A HK15111940A HK1210967A1 HK 1210967 A1 HK1210967 A1 HK 1210967A1 HK 15111940 A HK15111940 A HK 15111940A HK 1210967 A1 HK1210967 A1 HK 1210967A1
Authority
HK
Hong Kong
Prior art keywords
behavioural
prophylaxis
mental
treatment
combination
Prior art date
Application number
HK15111940.1A
Other languages
English (en)
Inventor
亞曆克斯埃文娜 莫洛佐娃 瑪格麗塔
杰羅維赫 貝妮亞薛維利 艾倫
愛德華維奇 札波洛思琪 馬克西姆
Original Assignee
Valenta Intellekt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2012141642A external-priority patent/RU2493838C3/ru
Application filed by Valenta Intellekt Ltd filed Critical Valenta Intellekt Ltd
Publication of HK1210967A1 publication Critical patent/HK1210967A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15111940.1A 2012-10-01 2015-12-03 用於行為、精神和認知障礙的預防和治療的組合物 HK1210967A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012141642A RU2493838C3 (ru) 2012-10-01 Комбинация для лечения и профилактики поведенческих, психических, когнитивных и неврологических нарушений при органических заболеваниях цнс
PCT/RU2012/000906 WO2014054965A1 (ru) 2012-10-01 2012-11-07 Комбинация для профилактики и лечения поведенческих, психических и когнитивных расстройств

Publications (1)

Publication Number Publication Date
HK1210967A1 true HK1210967A1 (zh) 2016-05-13

Family

ID=49253922

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111940.1A HK1210967A1 (zh) 2012-10-01 2015-12-03 用於行為、精神和認知障礙的預防和治療的組合物

Country Status (11)

Country Link
US (1) US9999614B2 (zh)
EP (1) EP2905021B1 (zh)
CN (1) CN104936584B (zh)
AU (1) AU2012391533B2 (zh)
CA (1) CA2886011C (zh)
EA (1) EA024489B1 (zh)
HK (1) HK1210967A1 (zh)
HU (1) HUE027934T2 (zh)
IL (1) IL238056A (zh)
UA (1) UA107653U (zh)
WO (1) WO2014054965A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3075038B1 (fr) 2017-12-15 2020-03-06 Melchior Material And Life Science France Utilisation de la fluoroethylnormemantine pour la prevention de l'apparition et le traitement de l'anxiete

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600723A (en) 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
DE58905637D1 (de) 1989-04-14 1993-10-21 Merz & Co Gmbh & Co Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie.
US5242941A (en) 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
US5614560A (en) 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US6469044B1 (en) 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
PL193237B1 (pl) 1997-06-30 2007-01-31 Merz Pharma Gmbh & Co Kgaa Pochodne 1-aminoalkilocykloheksanu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
CA2357114C (en) * 2001-03-22 2010-06-29 Pooger Properties Ltd. Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
CA2426492C (en) 2002-05-31 2006-10-03 H. Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
CA2500198A1 (en) * 2002-09-26 2004-04-08 Pooger Properties Limited Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
UA83645C2 (ru) 2002-10-24 2008-08-11 Мерц Фарма Гмбх Унд Ко. Кгаа Фармацевтический продукт, который содержит производное 1-аминоциклогексана и ингибитор ацетилхолинестеразы, его применение
CN1791423A (zh) 2003-03-19 2006-06-21 阿雷斯贸易股份有限公司 阿尔茨海默病的治疗
KR20070104480A (ko) 2003-05-27 2007-10-25 포레스트 래보러토리즈, 인코포레이티드 우울증 및 그 밖의 기분장애의 치료를 위한 ｎｍｄａ수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물
BRPI0512177A (pt) 2004-06-17 2008-02-12 Forest Laboratories formulação de liberação modificada de memantina
WO2006034465A1 (en) * 2004-09-23 2006-03-30 Merz Pharma Gmbh & Co. Kgaa Memantine for the treatment of childhood behavioral disorders
JP5666087B2 (ja) 2005-04-06 2015-02-12 アダマス・ファーマシューティカルズ・インコーポレーテッド Ｃｎｓ関連疾患の治療のための方法及び組成物
CA2604617C (en) 2005-04-28 2014-06-17 Eisai R&D Management Co., Ltd. Composition containing anti-dementia drug
CA2607600A1 (en) 2005-06-16 2006-12-28 Forest Laboratories, Inc. Modified and immediate release memantine bead formulation
KR20090024140A (ko) * 2006-05-22 2009-03-06 반다 파마슈티칼즈, 인코퍼레이티드. 우울증 질환에 대한 치료
BRPI0711872A2 (pt) 2006-05-22 2011-12-06 Vanda Pharmaceuticals Inc tratamento para distúrbios depressivos
WO2008005036A1 (en) 2006-07-05 2008-01-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions of memantine
GB0623897D0 (en) 2006-11-30 2007-01-10 Pliva Istrazivanje I Razvoj D Pharmaceutical composition of memantine
RU2326660C1 (ru) 2007-03-14 2008-06-20 Закрытое акционерное общество "Биологические исследования и системы" Пероральный лекарственный препарат мемантин (варианты) и способ его получения (варианты)
AU2008239683B2 (en) 2007-04-11 2014-03-27 Pharmaceuticals Productions Inc Melatonin tablet and methods of preparation and use
BRPI0811052A2 (pt) 2007-04-12 2015-01-27 Univ Minnesota Composições de proteção de isquemia/reperfusão e métodos de uso.
RU2336062C1 (ru) 2007-04-23 2008-10-20 Галина Ивановна Должич Способ лечения сложного миопического астигматизма

Also Published As

Publication number Publication date
HUE027934T2 (en) 2016-11-28
RU2493838C1 (ru) 2013-09-27
UA107653U (uk) 2016-06-24
US20150250763A1 (en) 2015-09-10
CA2886011A1 (en) 2014-04-10
EP2905021A4 (en) 2015-08-12
AU2012391533A1 (en) 2015-05-07
CA2886011C (en) 2018-01-16
EA201590547A1 (ru) 2015-07-30
WO2014054965A1 (ru) 2014-04-10
EP2905021B1 (en) 2016-04-27
CN104936584B (zh) 2017-12-15
IL238056A (en) 2017-09-28
US9999614B2 (en) 2018-06-19
EP2905021A1 (en) 2015-08-12
CN104936584A (zh) 2015-09-23
AU2012391533B2 (en) 2017-04-06
EA024489B1 (ru) 2016-09-30

Similar Documents

Publication Publication Date Title
ZA201503042B (en) Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
EP3068289A4 (en) Prevention and treatment of bed exits, falls, and other conditions
EP2827856A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES
HK1207860A1 (zh) 用於治療糖尿病及其相關病症的 -苯基- -雜環基-四氫- -吡喃- -胺化合物
EP2819587A4 (en) METHODS, APPARATUSES AND SYSTEMS FOR DIAGNOSING AND TREATING MOOD DISORDERS
IL280144A (en) Use of telomerase inhibitors to treat bone marrow culture disorders and bone marrow culture tumors
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
HK1205467A1 (zh) 用於預防和治療精神、行為和認知障礙的藥物組合物
HK1207593A1 (zh) 用於治療精神和行為病症的藥物
ZA201607980B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
IL235127A (en) Hpn-100 for use in the treatment of nitrogen-related diseases
HK1203054A1 (zh) 治療疼痛的二核苷多磷酸鹽
ZA201408060B (en) Compositions and methods for the treatment of neurological disorders
IL237912A0 (en) History of dihydro-6-azaphenylene for the treatment of the central nervous system, oncological diseases and similar disorders
ZA201408061B (en) Compositions and methods for the treatment of neurological disorders
HK1210967A1 (zh) 用於行為、精神和認知障礙的預防和治療的組合物
GB201219696D0 (en) Agents for the prevention and/or treatment of central nervous system damamge

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE CHINESE NAME OF INVENTOR FROM